AMLX - Amylyx Pharmaceuticals, Inc.

QQQ $ 478.67 $ -0.10 (-0.02 %)

DIA $ 410.83 $ 3.35 (0.82 %)

SPY $ 560.31 $ 0.78 (0.14 %)

TLT $ 98.26 $ 0.07 (0.07 %)

GLD $ 232.04 $ 1.08 (0.47 %)

Previous Close

$ 2.22

Open

$ 2.23

Bid

$ 2.26 x 300

Ask

$ 2.27 x 213

Day's Range

$ 2.21 - $ 2.28

52 Week Range

$ 1.58 - $ 22.36

Volume

508,606

Average Volume

Market Cap

151.14M

Beta (5Y Monthly)

$ 0.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-22-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-13-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-31-2022	12-31-2021	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Amylyx Pharmaceuticals Announces Publicati...
08/12/2024 13:06:33

- Findings from exploratory analysis of the PEGASUS trial provide preliminary evidence that AMX0035 engages multiple pathologic...

Amylyx Pharma Q2 2024 Adj. EPS $(0.73), In...
08/08/2024 11:15:05

Amylyx Pharma (NASDAQ:AMLX) reported quarterly losses of $(0.73) per share which met the analyst consensus estimate. The compa...

Amylyx Pharmaceuticals Announces European ...
08/02/2024 13:01:48

Analyst Ratings For Amylyx Pharma
07/12/2024 19:01:19

nvidia-to-rally-more-than-33-here-are-10-top-analyst-forecasts-for-friday

NVIDIA To Rally More Than 33%? Here Are 10...
07/12/2024 13:01:36

Goldman Sachs Maintains Neutral on Amylyx ...
07/12/2024 10:09:10

Goldman Sachs analyst Chris Shibutani maintains Amylyx Pharma (NASDAQ:AMLX) with a Neutral and raises the price target from ...

why-is-small-cap-amylyx-pharmaceuticals-stock-trading-higher-on-wednesday

Why Is Small Cap Amylyx Pharmaceuticals St...
07/10/2024 19:32:36

Amylyx Pharmaceuticals acquired avexitide from Eiger BioPharmaceuticals Inc. for $35.1 million. Avexitide, a GLP-1 receptor ant...

HC Wainwright & Co. Reiterates Buy on Amyl...
07/10/2024 17:25:58

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

Amylyx Pharmaceuticals Acquired Avexitide ...
07/10/2024 11:04:34

As part of the transaction, Amylyx assumed certain contractual obligations from Eiger, including a 3% royalty on future sales o...

Amylyx Pharmaceuticals To Host Conference ...
07/09/2024 20:33:05

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced that Amylyx' managem...

6 Analysts Assess Amylyx Pharma: What You ...
06/24/2024 12:00:23

HC Wainwright & Co. Reiterates Buy on Amyl...
06/24/2024 10:22:57

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

Mizuho Maintains Neutral on Amylyx Pharma,...
05/14/2024 10:47:43

Mizuho analyst Graig Suvannavejh maintains Amylyx Pharma (NASDAQ:AMLX) with a Neutral and lowers the price target from $4 to...

Breaking Down Amylyx Pharma: 9 Analysts Sh...
05/10/2024 18:01:12

HC Wainwright & Co. Reiterates Buy on Amyl...
05/10/2024 12:25:27

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

Amylyx Pharma Cash, Cash Equivalents And ...
05/09/2024 12:04:14

Amylyx Pharma Q1 2024 GAAP EPS $(1.75)May ...
05/09/2024 12:03:33

Baird Maintains Neutral on Amylyx Pharma, ...
04/11/2024 10:43:32

Baird analyst Joel Beatty maintains Amylyx Pharma (NASDAQ:AMLX) with a Neutral and lowers the price target from $4 to $3.

HC Wainwright & Co. Reiterates Buy on Amyl...
04/11/2024 10:29:38

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

amylyx-pharmaceuticals-investigational-drug-shows-improved-pancreatic-function-in-patients-with-inherited-disorder

Amylyx Pharmaceuticals' Investigational Dr...
04/10/2024 17:14:44

Amylyx's AMX0035 data in treating Wolfram syndrome, with interim data indicating positive effects on diabetes progression, ...